Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Bioorganic & Medicinal Chemistry
|
June 18, 1998
Synthesis and antiviral activity of prodrugs of the nucleoside 1-[2',3'-dideoxy-3'-C-(hydroxymethyl)-beta-D-erythropentofuranosyl] cytosine
S C Mauldin, C J Paget, C D Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1993
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors
J Balzarini, A Karlsson, A M Vandamme, et al.
Virology
|
January 1, 1993
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase
J Balzarini, A Karlsson, M J Pérez-Pérez, et al.
Journal of Medicinal Chemistry
|
October 3, 1999
Design and fast synthesis of C-terminal duplicated potent C(2)-symmetric P1/P1'-modified HIV-1 protease inhibitors
M Alterman, H O Andersson, N Garg, et al.
Journal of Medicinal Chemistry
|
October 9, 1999
Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues
M Högberg, C Sahlberg, P Engelhardt, et al.
Journal of Medicinal Chemistry
|
October 11, 1996
Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs
A S Cantrell, P Engelhardt, M Högberg, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Bioorganic & Medicinal Chemistry
|
June 18, 1998
Synthesis and antiviral activity of prodrugs of the nucleoside 1-[2',3'-dideoxy-3'-C-(hydroxymethyl)-beta-D-erythropentofuranosyl] cytosine
S C Mauldin, C J Paget, C D Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1993
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors
J Balzarini, A Karlsson, A M Vandamme, et al.
Virology
|
January 1, 1993
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase
J Balzarini, A Karlsson, M J Pérez-Pérez, et al.
Journal of Medicinal Chemistry
|
October 3, 1999
Design and fast synthesis of C-terminal duplicated potent C(2)-symmetric P1/P1'-modified HIV-1 protease inhibitors
M Alterman, H O Andersson, N Garg, et al.
Journal of Medicinal Chemistry
|
October 9, 1999
Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues
M Högberg, C Sahlberg, P Engelhardt, et al.
Journal of Medicinal Chemistry
|
October 11, 1996
Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs
A S Cantrell, P Engelhardt, M Högberg, et al.
Page
of 3